# clm_393DB4682B31

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 4,383,000,000 United States dollar  
valid_from: 2017-09-30  
valid_to: 2018-03-31  
published: 2017-11-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_72F018D1F42C  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 4,383,000,000 United States dollar", as of 2017-09-30 (until 2018-03-31). Claim clm_393DB4682B31, https://asof.is/claim/clm_393DB4682B31, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-11-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm (primary, SEC EDGAR 10-Q Q3 FY2017, published 2017-11-07)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 1,749,000,000 United States dollar | valid 2017-06-30 to 2017-09-30 | conf 0.95 | superseded | superseded_by [clm_393DB4682B31](/claim/clm_393DB4682B31.md) | [clm_3B507E46CC5D](/claim/clm_3B507E46CC5D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
